Furthermore, the risks of myocardial infarction (HR 0.91, 95% CI 0.840.98 with GLP-1RAs and HR 0.89, 95% CI 0.800.98 with SGLT2is) and cardiovascular death (HR 0.88, 95% CI 0.800.96 with GLP-1RAs and HR 0.84, 95% CI 0.750.94 with SGLT2is) were similarly reduced in both GLP-1RA and SGLT2i groups, while the risk of stroke was reduced only with GLP-1RAs (HR 0.86, 95% CI 0.770.97 with GLP-1RAs and HR 0.97, 95% CI 0.861.10 with SGLT2is)
Don and Jason are both in the growing population of riders who are benefiting from GLP-1 drugs like Ozempictheyre quick to note that these powerful peptides arent for everyone, but for those suffering from obesity-related health conditions, they can be a game changer, or even a lifesaver
Standard dosing Typical dose: 1 mL per injection Frequency: Once weekly for maintenance, twice weekly for active weight loss Duration: 12-16 weeks initially, with reassessment before continuing Some providers recommend starting with twice-weekly injections during the first 4-8 weeks of a weight loss program, then transitioning to weekly maintenance injections once you've reached your goal weight
If your genetic profile shows lower GLP-1 receptor sensitivity or variants associated with stronger hunger signals, you're likely among those who experience rapid rebound after discontinuation